TARA FY 2017 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$211M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$148,000

Operating Income

-$30M

Net Income

-$30M

EPS (Diluted)

$-69.38

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$925

Balance Sheet

Total Assets

$44M

Total Liabilities

$9M

Stockholders' Equity

$35M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$148,000	-$123,000	-20.3%
Operating Income	-$30M	-$29M	-5.8%
Net Income	-$30M	-$29M	-5.0%